IT
Inflammasome Therapeutics, Inc.
SEC filingBiotechnology · Newton, MA
Amount raised$13.2Msold at filing
Total offering$13.2M
Investors in the raise62count reported to the SEC
FiledMay 4, 2026first sale Feb 27, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Balamurali K. AmbatiExecutive Officer, Director
Jayakrishna AmbatiExecutive Officer, Director
Chaniyilparampu N. RamchandDirector
Babur B. LateefDirector
Napoleone N. FerraraDirector
Executive officers, directors and promoters as listed on the Form D.